Aloe vera may cause hypokalemia and inducing digitalis toxicity and cardiac arrhythmias in patients with heart failure Butcher's broom is mainly indicated for circulatory disorder and it reduced the effect ofadrenoceptor effects in patients with hypertension and heart failure Capsicum which is indicated for shingles, trigeminal and diabetic neuralgia may elevate the blood pressure in patients treated with monoamine oxidase inhibitors Fumitory used as hypotensive agent and enhances the effects

more »

... -adrenoceptors, calcium entry blockers and glycosides. Ginseng causes high blood pressure Gossypol, a male contraceptive increases the effect of diuretics and causes hypokalemia Grape fruit juice augments the cardiac effects of calcium entry blockers Hawthorn potentiates the actions of glycosides and nitrite Irish moss potentiates the antihypertensives effects Kelp increases the effects of antihypertensives Khella increases the cardiac actions of calcium entry blockers Licorice increases the blood pressure and causes hypokelemia which potentiates the www.intechopen.com Coronary Artery Diseases 182 Lily of the valley increases effects of -aderenoceptor, calcium entry blockers, digitalis and quinidine Ma-huang (ephedra) increases heart rate and blood pressure Oleander increases the effect of angiotensin converting enzyme inhibitors, antiarrhythmics, -adrenoceptor blockers, calcium entry blockers and cardiac glycosides. St. John's wort induces arrhythmias, heart block, hyperkalemia and death Strophanthus increases heart rate and blood pressure in patients treated ith monoamine oxidase inhibitors Yohimbine increases heart rate and induces changes in blood pressure Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappe DL, Jensen KR, Horne BD, Carter MA, Anderson JL. Intermountain Heart Collaborative Study Group. Effect of betablocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure. Am J Cardiol 2005; 95:827-831 Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003; 57: 193-200 Chaitman B R. Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directions. Can J Cardiol 2005; 21:1031-1034 C h a t t e r j e e S S , K o c h E , J a g g y H , K r z e m i n s k i T . I n v i t r o a n d i n v i v o s t u d i e s o n t h e cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms. Arzneimittel-Forschung 1997; 47:821-825 Chen CF, Yeh SU, Chien CT, Wu MS. Renal response during acute unilateral ureteral obstruction in rats. Neurourol Urodyn 2001; 20:125-137 Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004; 78(5):1536-1541 Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev 2005. 19CD003614 Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997; 337: 447-452 Cohen ML. 3 -receptors mediate relaxation in stomach fundus whereas a fourth receptor mediates tachycardia in atria from transgenic 3 -receptor knockout mice. Receptors Channels 2000; 7:17-23 Colantuoni A, Bertuglia S, Magistretti MJ, Donato L. Effects of Vaccinium myrtillus anthocyanosides on arterial vasomotion. Arzneim Forsch/Drug Res 1991; 41:905-909 Colin P, Ghaleh B, Monnet X, Su J, Hittinger L, Giudicelli JF, Berdeaux A.. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 2003; 284:H676-H682 Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration [published erratum